Intrinsiqs

Is STAAR Surgical Company overvalued?

STAAR Surgical Company (STAA) looks overvalued — trading about 40% above its fair value.

Overvalued
Current price $26.39 Fair value $15.94
Price
$26.39
Fair value
$15.94
Current P/E
46.3
Normal P/E
28.0
Market cap
$1.32B
Dividend yield
0.0%
Return on equity
0.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares STAA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.